Breaking News, Collaborations & Alliances

CMC, inspiration in Bulk Bio Pact

CMC to make commercial supply of hemophilia B treatment

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

CMC Biologics and Inspiration Biopharmaceuticals have entered into a long-term commercial supply agreement for the manufacture of bulk IB1001, Inspiration’s intravenous recombinant factor IX (rFIX) product, for the treatment and prevention of bleeding in individuals with hemophilia B. CMC will be the exclusive manufacturer of bulk IB1001 for at least six years; commercial supply manufacturing is expected to begin this fall. Financial terms were not disclosed. “We are extremely excit...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters